Erik C. Chelius

Erik C. Chelius discloses dealings in Endocyte Inc to SEC (Form 4). We count 7 filings; the first trade dates from 8 February 2018 and the latest from 21 December 2018.

Every open-market trade on record is a sale: 1 sale worth €61k. Outside the open market, there are 1 share grant.

The latest filing, published on 21 December 2018, reports a transaction of €332k in Endocyte Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.